Recently, Astragaloside IV has been proven to ameliorate renal fibrosis by inhibiting inflammation via the toll-like receptor 4 (TLR4)/NF-кB signaling pathway in UUO mice (Zhou et al., 2017). This evidence concerns the gene TLR4 and renal fibrosis.